XNAS · Healthcare · Diagnostics & Research
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Q1 2026 | 3.41 | 3.47 | +1.76% | $1.14B | ✅ Beat | +0.16% | -5.16% | — |
| 2026-02-02 | Q4 2025 | 2.93 | 3.08 | +5.12% | $1.09B | ✅ Beat | +2.91% | +0.03% | +1.42% |
| 2025-11-03 |
| Q3 2025 |
| 3.14 |
| 3.22 |
| +2.55% |
| $1.10B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-04 | Q2 2025 | 3.30 | 3.50 | +6.06% | $1.11B | ✅ Beat | +4.57% | -4.49% | -7.15% |
| 2025-05-01 | Q1 2025 | 2.85 | 2.91 | +2.11% | $998.4M | ✅ Beat | +0.11% | +3.95% | +9.21% |
| 2025-02-03 | Q4 2024 | 2.40 | 2.53 | +5.42% | $954.3M | ✅ Beat | -0.85% | -0.88% | -6.78% |
| 2024-10-31 | Q3 2024 | 2.68 | 2.79 | — | $975.5M | ➖ Inline | +2.55% | +6.41% | +5.86% |
| 2024-08-06 | Q2 2024 | 2.87 | 3.02 | +5.23% | $1.00B | ✅ Beat | -0.49% | +3.93% | -0.04% |
Showing last 8 quarters.